Becker A, Stoffels-Weindorf M, Schimming T, Dissemond J
Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie der Universitätsklinik Essen, Germany.
Dtsch Med Wochenschr. 2013 Jul;138(28-29):1458-62. doi: 10.1055/s-0033-1343293. Epub 2013 Jul 2.
A 50-year-old women had suffered from recurrent and extremely painful ulcerations of both legs and the back of her feet for about 3 weeks. The clinical examination showed multiple hemorrhagic and bizarre configured ulcerations with a surrounding livid-erythematous discoloration, hyperpigmentation and extensive atrophie blanche.
Neither instrument-based nor serological tests revealed specific pathological findings. Histological results from the border area of the ulceration confirmed the diagnosis of livedoid vasculopathy.
A systemic treatment with low-molecular-weight heparin was initiated, resulting in a rapid pain reduction and complete healing of the ulcerations after some weeks of therapy.
This case report demonstrates that unusual entities like livedoid vasculopathy should be considered as rare causes for recurrent leg ulcers because different underlying etiologies need different specific treatment strategies. Until now treatment for patients with livedoid vasculopathy has not been standardized but anticoagulative therapy with low-molecular-weight heparin is considered to be one treatment of first choice.
一名50岁女性双下肢及足背反复出现剧痛性溃疡约3周。临床检查发现多处出血性且形态怪异的溃疡,周围有青紫色红斑、色素沉着及广泛的白色萎缩。
基于仪器的检查及血清学检查均未发现特异性病理结果。溃疡边缘区域的组织学检查结果确诊为萎缩性血管病。
开始使用低分子肝素进行全身治疗,治疗数周后疼痛迅速减轻,溃疡完全愈合。
本病例报告表明,萎缩性血管病等罕见病症应被视为复发性腿部溃疡的罕见病因,因为不同的潜在病因需要不同的特异性治疗策略。目前,萎缩性血管病患者的治疗尚未标准化,但低分子肝素抗凝治疗被认为是首选治疗方法之一。